Setting the Course
Guest Post by Matthew J. Sikora, PhD University of Pittsburgh Cancer Institute
Guest Post by Matthew J. Sikora, PhD University of Pittsburgh Cancer Institute
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
Philadelphia Eagles player Rodney McLeod he has looked to honor his grandmother’s memory by supporting the American Association for...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...
T-DM1, a HER2-targeted antibody-drug conjugate, improved outcomes for patients with HER2-positive, metastatic breast cancer that had progressed despite prior...
As we head into summer, enjoy this month’s selection of studies spotlighted by the editors of the 10 AACR...
As the 2018 Annual Meeting of the American Association for Cancer Research unfolded yesterday morning, the excitement among the...
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
“These are extraordinary times,” began Hugh Auchincloss, MD, as he opened up the recent NIH-AACR Cancer, Autoimmunity, and Immunology...
A study presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium found that women who received breast...
Guest Post by Jenine Sanzari, PhD Stand Up To Cancer recently held its seventh annual Scientific Summit, organized by...
The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at...
The screen goes blue, that unmistakable tune starts playing, and the voice of Johnny Gilbert announces, “This. Is. Jeopardy!” We meet the contestants. We hear...
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
Today, the American Association for Cancer Research (AACR), in conjunction with its Fellows of the AACR Academy, Rep. André...
Guest Post by Scott M. Lippman, MD UC San Diego Moores Cancer Center
Stepping onto the exhibit floor at an Annual Meeting poster session is a memorable experience. Row upon row of...
The COVID-19 pandemic has taken a devastating toll, with 5.8 million deaths worldwide, including nearly 1 million in the...
As 2019 draws to a close, the American Association for Cancer Research (AACR) is grateful for our growing ranks...
Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference,...
Every person who hears the words “you have cancer” has a unique story. As part of Cancer Today’s mission...
In addition to the robust scientific program at this year’s AACR Annual Meeting in Washington, D.C., a number of...
A childhood cancer survivor becomes a childhood cancer researcher.
Liquid biopsies, noninvasive tests performed on biofluids to detect genetic alterations in tumors, are a recent revolution in the...
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...